VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

BTOG 2018 | Identifying non-invasive biomarker assays for lung cancer: what is an appropriate control group?

A non-invasive biomarker assay to detect lung cancer would be ideal; avoiding needless biopsies and providing another step of diagnostic validation. However, finding the optimal control group to identify these signatures is not easy, as explained here by Robert Rintoul, PhD, FRCP, of the Cancer Research UK Cambridge Institute, Cambridge, UK. This video was recorded at the British Thoracic Oncology Group (BTOG) Annual Conference 2018, held in Dublin, Ireland.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter